PROGLYCEM Drug Patent Profile
✉ Email this page to a colleague
When do Proglycem patents expire, and what generic alternatives are available?
Proglycem is a drug marketed by Teva Branded Pharm and is included in two NDAs.
The generic ingredient in PROGLYCEM is diazoxide. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the diazoxide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Proglycem
A generic version of PROGLYCEM was approved as diazoxide by E5 PHARMA INC on December 20th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROGLYCEM?
- What are the global sales for PROGLYCEM?
- What is Average Wholesale Price for PROGLYCEM?
Summary for PROGLYCEM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 112 |
| Clinical Trials: | 6 |
| Patent Applications: | 3,821 |
| Drug Prices: | Drug price information for PROGLYCEM |
| What excipients (inactive ingredients) are in PROGLYCEM? | PROGLYCEM excipients list |
| DailyMed Link: | PROGLYCEM at DailyMed |
Recent Clinical Trials for PROGLYCEM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Columbia University | Phase 1 |
| Albert Einstein College of Medicine, Inc. | Phase 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
US Patents and Regulatory Information for PROGLYCEM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | PROGLYCEM | diazoxide | CAPSULE;ORAL | 017425-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Branded Pharm | PROGLYCEM | diazoxide | CAPSULE;ORAL | 017425-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Branded Pharm | PROGLYCEM | diazoxide | SUSPENSION;ORAL | 017453-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
